Global Biopsy Devices Market Size, Share, and COVID-19 Impact Analysis, By Product (Needle-based Biopsy Guns, Biopsy Guidance Systems, Biopsy Forceps, Biopsy Needles), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2021 – 2030Industry: Healthcare
Global Biopsy Devices Market Insights Forecasts to 2030
- The Biopsy Devices Market was valued at USD 2.52 Billion in 2021.
- The Market is growing at a CAGR of 7.9% from 2022 to 2030
- The Worldwide Biopsy Devices Market is expected to reach USD 3.98 Billion by 2030
- Asia Pacific is expected to grow the fastest during the forecast period
Get more details on this report -
The global Biopsy Devices Market is expected to reach USD 3.98 Billion by 2030, at a CAGR of 3.98% during the forecast period 2022 to 2030.
In general, malignant and inflammatory disorders are the focus of biopsies, which include the surgical removal of tissue from an organ to ascertain the presence or severity of a disease. Radiologists, interventional cardiologists, and surgeons typically perform it. As a confirmatory test for cancer and celiac disease, biopsies can be carried out on any organ using specialised biopsy equipment. Each biopsy tool has a different application depending on the type of organ being studied. Advanced imaging technologies, such as MRI-guided biopsy, stereotactic-guided biopsy, ultrasound-guided biopsy, CT scan, and others, can be used in conjunction with conventional biopsy devices to perform biopsy with accuracy and less invasiveness. The lungs, liver, and kidneys are just a few of the body organs whose biopsies are carried out using these integrated techniques.
Impact of COVID 19 On Global Biopsy Devices Market
Over the COVID 19 pandemic, the global biopsy devices market was affected owing to the decrease the number of biopsy methods due to the restrictions in the pandemic. As per the study published on Impact of the COVID 19 pandemic on surgical practice, in May 2020, All specialties had produced suggestions by May 2020 for how to handle this crisis, which has had a significant influence on surgical practise. Every discipline has had to rank the significance of their routine surgical operations and, when possible, investigate non-surgical treatment solutions. The surge in non-surgical treatments and the avoidance of surgical procedures contributed to negative market expansion during the epidemic.
Global Biopsy Devices Market Report Coverage
|Market Size in 2021:||USD 2.52 Billion|
|Forecast Period 2021-2030 CAGR:||7.9%|
|2030 Value Projection:||USD 3.98 Billion|
|Historical Data for:||2017-2020|
|No. of Pages:||200|
|Tables, Charts & Figures:||100|
|Segments covered:||By Product, By Region and COVID-19 Impact Analysis|
|Companies Covered:||Argon Medical Devices, Inc., B. Braun Melsungen AG, Becton Dickinson and Company (C.R. Bard, Inc.), Boston Scientific Corporation, Cardinal Health, Inc., Cook Medical, Inc., Danaher Corporation (Leica Microsystem), Fujifilm Holdings Corp., Hologic, Inc., Medtronic plc|
|Pitfalls & Challenges:||COVID-19 Empact, Challenge, Future, Growth, & Analysis|
Get more details on this report -
Key Driving Factors
Increasing cases of cancer is driving the market growth
The rising prevalence of cancer across the world is contributing towards the rise in the demand of biopsy devices. For instance, in 2022, around 1.9 million new cancer cases have been detected in the U.S. as per the report published by the American Cancer Society. The increasing cases of cancer is promoting the key market players to come up with the more effective, advanced, and safe biopsy procedures. Apart from this, the invasive medical procedures provide various benefits which is increasing their popularity. These medical procedures help the patients to recover quicky and are less traumatic. Many reports stated that minimally invasive surgeries are replaced by invasive surgeries as well as offering higher patient satisfaction levels.
Demand for less invasive surgeries is propelling the market growth
The rise in the demand for less invasive surgeries as well as disposable biopsy devices is likely to drive the growth of the global biopsy devices market. Certain medically advanced biopsy guidance systems like vacuum assisted guns are witnessing huge popularity among healthcare providers and patients. In addition, the increasing geriatric population and the launch of advanced and effective devices are also propelling the market growth.
Needle based biopsy guns segment holds the largest market share over the forecast period
On the basis of product, the global biopsy devices market is segmented into needle based biopsy guns, biopsy guidance systems, biopsy forceps, biopsy needles. Among these, the needle based biopsy guns segment is dominating the market with the largest market share over the forecast period. The growth is attributed to the increasing demand for these guns to get samples from soft tissues of various internal organs like breasts, kidneys, and lungs which contributing towards the overall growth of the segment over the forecast period. Apart from this, the increasing demand for gentle and rapid procurement of cell samples for biopsy is also another factor which propelling the demand of the segment.
North America is dominating the market with the largest market share over the forecast period
Get more details on this report -
North America is dominating the market with the largest market share over the forecast period owing the strong presence of the key market players which is going to continue its dominance over the upcoming years. Furthermore, the increasing market penetration rates of technologically advances equipment like vacuum assisted biopsy systems as well as increasing demand for disposable devices are anticipated to drive the regional market growth.
Asia Pacific, on the other hand is witnessing the fastest market growth due to the improvements in the healthcare infrastructure in various developing economies, the presence of increasing demand of the patients, as well as the rising cases of cancer are estimated to the fuel the regional market growth.
Recent Market Developments
- In August 2022, Devicor Medical Product, Inc. has made an announcement about the launch of the Mammotome DualCore Dual Stage Core Biopsy System.
List of Key Market Players
- Argon Medical Devices, Inc.
- B. Braun Melsungen AG
- Becton Dickinson and Company (C.R. Bard, Inc.)
- Boston Scientific Corporation
- Cardinal Health, Inc.
- Cook Medical, Inc.
- Danaher Corporation (Leica Microsystem)
- Fujifilm Holdings Corp.
- Hologic, Inc.
- Medtronic plc
This study forecasts revenue at global, regional, and country levels from 2019 to 2030. Spherical Insights has segmented the global Biopsy Devices Market based on the below-mentioned segments:
Biopsy Devices Market, Product Analysis
- Needle based Biopsy Guns
- Biopsy Guidance Systems
- Biopsy Forceps
- Biopsy Needles
Biopsy Devices Market, Regional Analysis
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- South America
- Rest of South America
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
Frequently Asked Questions (FAQ)
1. What is the market size of Biopsy Devices Market?The global Biopsy Devices Market is expected to grow from USD 2.52 Billion in 2021 to USD 3.98 Billion by 2030, at a CAGR of 7.9% during the forecast period 2022-2030.
2. Who are the key market players of Biopsy Devices Market?Some of the key market players of Biopsy Devices Market are Argon Medical Devices, Inc., B. Braun Melsungen AG, Becton Dickinson and Company (C.R. Bard, Inc.), Boston Scientific Corporation, Cardinal Health, Inc., Cook Medical, Inc., Danaher Corporation (Leica Microsystem), Fujifilm Holdings Corp., Hologic, Inc., and Medtronic plc.
3. Which segment hold the largest market share?Needle based biopsy guns hold the largest market share is going to continue its dominance.
4. Which region is dominating the Biopsy Devices Market?North America is dominating the Biopsy Devices Market with the highest market share.
Need help to buy this report?